These findings show that in these patients, most of whom had a low cardiac output, afterload reduction with ventricular pacing increased resting cardiac output more than physiological pacing alone. Nevertheless, persistence of high filling pressures despite afterload reduction may limit the potential therapeutic benefit. Care should be taken in extrapolating these data to other patient groups.
suAlMARY The effect of afterload reduction was studied in a group of patients who remained breathless or tired after permanent ventricular pacing. Haemodynamic measurements were made before and after giving hydralazine 20 mg intravenously using a triple lumen thermodilution catheter and cuff blood pressure recordings during ventricular pacing at the standard rate of 71/min or an increased rate of 88/min and physiological pacing. Increasing the ventricular pacing rate had no effect on cardiac output as stroke volume fell. Hydralazine produced a greater rise in cardiac output than physiological pacing alone, although peak values were obtained by combining the two. Ventricular pacing produced intermittent large left and right atrial pressure peaks. Physiological pacing produced no such peaks, and mean right and left atrial pressures fell. Hydralazine did not significantly alter atrial pressures.
These findings show that in these patients, most of whom had a low cardiac output, afterload reduction with ventricular pacing increased resting cardiac output more than physiological pacing alone. Nevertheless, persistence of high filling pressures despite afterload reduction may limit the potential therapeutic benefit. Care should be taken in extrapolating these data to other patient groups.
Technical improvement in dual chamber pacing systems is leading to their more widespread use and to a parallel increase in controversy regarding the indications for atrioventricular pacing.1 2 Atrioventricular sequential pacing has been shown to give a higher cardiac output than conventional ventricular pacing in patients with complete heart block after cardiac surgery3 or acute myocardial infarction. 4 were then repeated after giving the arteriolar dilating drug hydralazine.
Patients and methods
Ten patients (six men and four women) were studied. Their ages ranged from 28 to 78 (mean 62) years. All had symptoms of dyspnoea or fatigue on moderate (seven) or mild (three) exertion (NYHA classes II and III) despite ventricular pacing. The indication for pacing was complete heart block in five patients, persistent 2:1 atrioventricular block in three, and intermittent bradycardia in two. All the patients had impaired left ventricular function as assessed by gated blood pool radionucide ventriculography, with resting ejection fractions ranging from 12% to 43% (mean 30%). All patients were receiving diuretics, but only one had clinical evidence of pulmonary congestion at the time of the study. The study was approved by the local ethical committee, and all patients gave their informed consent. Six patients were studied at the time of elective pacing system revision, and the remaining four within three weeks of implantation of a multiprogrammable atrioventricular pacing system. In the first group a Cordis atrial J shaped lead was inserted via the subclavian vein and positioned for atrial sensing or pacing or both. The existing ventricular lead was used for ventricular stimulation. In all patients a triple lumen thermodilution Swan-Ganz catheter was inserted percutaneously and passed to the pulmonary artery with the proximal lumen opening into the right atrium. Right atrial pressure, pulmonary artery pressure, and pulmonary artery wedge pressure were measured.
Cardiac output measurements were made in triplicate. Systemic arterial pressure was measured using a sphygmomanometer cuff on'the left or right arm. All patients were studied after an overnight fast and in the recumbent position.
Three different pacing patterns were used, and their order for individual patients randomised: (a) standard rate ventricular pacing (mean 71/min); (b) increased rate ventricular pacing (mean rate 88/min); and (c) atrial triggered pacing in nine patients or atrial pacing in one patient. Each pacing pattern was instituted for 10 minutes. Measurements were made when a steady state had been achieved. When measurements had been completed for each of the three patterns of pacing, hydralazine 20 mg was infused intravenously over 15 minutes, and a further 20 minutes allowed to elapse before the different pacing patterns were repeated, again in random order.
Results
The results are shown in Tables 1 and 2 Fig. 1 ).
There was no significant difference between the standard rate and increased rate of ventricular pacing Fig. 4 ).
AFTER HYDRALAZINE
Cardiac output increased by approximately 300/a from 3.9+ 1-2 to 5.0+1-0 (p<0-01) at the standard ventricular pacing rate as a result of a similar increase in stroke volume (Tables 1 and 2 , Fig. 1 ). Mean systemic arterial pressure fell from 97 9t 15.5 mm Hg to 80-2+ 12-2 mmHg (p<001) (Fig. 4) pressure from 13-9±3-2 to 17*1+4.6 (Fig. 2 ). There were no significant changes in mean or peak pulmonary artery wedge pressures, although peak wedge pressures tended to rise (Fig. 3) . There was no significant change in cardiac output or in atrial pressures when the ventricular pacing rate was increased to 88/min; as before, the increase in rate was compensated for by a fall in stroke volume.
With atrial triggered pacing mean heart rate after hydralazine treatment was 82/min compared with 77/min before hydralazine treatment; cardiac output was 42% greater than before hydralazine and 56% greater than with ventricular pacing before hydralazine, although this further increase was not statistically significant (Fig. 1) 
